37
DAFTAR PUSTAKA
1. Kliegman R, Behrman R, Jenson H. Leukemia. Tubengen D, penyunting.Dalam : Nelson textbook of pediatric. Edisi ke-18.Philadelphia. 2007
2. Smith M.A, Ries G, Gurney J. Leukemia. SEER Pediatric monograph. National cancer institute.17-21. Diunduh dari Http//www. seer.cancer.gov/publications/childhood/leukemia. Di akses tanggal 4 Oktober 2013.
3. Atra A, Pinkerton C, Bouffet E, Norton A, Hobson R, Imeson J, Gerrard M. Acute neurotoxicity in children with advanced stage B-non-hodgkin’s lymphoma and B- acute Lymphoblastic leukemia treated with the united kingdom children cancer study group 9002/9003 protocols. Eur J Cancer. 2004; 40: 1346-50
4. Rahman A, Mannan M, Sadeque S. Acute and long- term neurological complications in children with acute lymphoblastic leukemia. Bangladesh med res. 2004; 34:90-3
5. Brzezinski K. Chemoterapi-induced peripheral neuropathy. Wapolczesna Onkol.2012;16(3):258- 63
6. Gilchrist L. Chemotherapy-induced peripheral neuropathy in pediatric cancer patients. Semin Pediatr Neurol.2012;19:9-17
7. Reinders M, van weerden TW, Fock JM, Gidding CE, Vingerhoets HM, et al. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukemia. Eur J Pediatr Neurol.2000;4(5):225-233
8. Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J et al. Vincristine- induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a pediatric Oncology Group study. J Pediatr Hematol Oncol. 2003;25(4):316-320
9. Ariawati K, Windiastuti E, Gatot D. Toksisitas kemoterapi leukemia limfoblastik akut pada fase induksi dan profilaksis susunan saraf pusat dengan metotreksat 1 gram. Sari pediatri. 2007;9:252-7
10. Vagace M , Gervasini G. Chemotherapy toxicity in patients with acute leukemia. Dalam : Mariastefnia A , penyunting. Acute Leukemia- the scientist’s perspective and challenge. Shanghai: Intech Europe, 2011.h.392-413
38
12. Park S, Krisnan A, Lin S, Goldstein D, Friendlander M, Kiernan M. Mechanisms underlying chemotherapy- induced neurotoxicity and the potential for neuroprotective stragies. Current Medical Chemistry. 2008;15:3083-94
13. Smith O, Hann I. Clinical features and therapy of lymphoblastic leukemia. Dalam :Arceci R, penyunting. Pediatric hematology.Edisi ke-3. Blackwell. 2006.h. 450-81
14. Permono B, Ugrasena I. Leukemia akut. Dalam : Permono B,Sutaryo, Ugrasena, Windiastuti, Abdulsalam M, penyunting. Buku ajar hematologi – onkologi anak cetakan ketiga. Jakarta : Ikatan dokter anak Indonesia,2010.h. 237-47
15. Azhary H, Farooq M, Bhanushali M, Majid A, Kassab M. Periferal neuropathy: differential diagnosis and management. Am Fam Physician.2010;81(7):887-92
16. Swaiman F, Ashwal S, Ferriero D. Peripheral neuropathies. Dalam : Susan P, penyunting.Pediatric neurology principles and practice, edisi ke-4. Minnesota: Elsivier, 2006.h.1888- 905
17. Schlegel U. Central nervous system toxicity of chemotherapy. European association of neurooncology magazine. 2008;1(1) :25-9
18. Sul J, DeAngelis L. Neurologic complications of cancer chemotherapy.Semin Oncol. 2006;33:324-32
19. Edward J, Dropcho. Neurotoxicity of cancer chemotherapy.World Health Organization.2004;24:420-56
20. Brenner L, Evans W. Rationale for high-dose methotrexate in childhood acute lymphoblastic leukemia. Ching-Hon Pui,penyunting.Dalam :Treatment of acute leukemias new directions for clinical research. Totowa:Humana press.h.339-61
21. Han y, Smith M. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN). Frontiers. 2013;4:1-16
22. Andreas A, Argyriou, Bruna J, marmiroli P, Caveletti G. Chemotherapy induced peripheral neurotoxicity (CIPN): An update. Elsivier. 2011;82:51-77 23. Brigo F, balter R, Marradi P, Ferlisi M, Zaccaron A,et al. Vincristine-related
neuropathy in children with acute lymphoblastic leukemia. J child Neurol.2012;27(7):867-874
24. Gomber S, dewan P, Chonker D. Vincristine induced neurotoxicity in cancer patients. Ind J pediatr. 2010;77(1):97-100
39
26. Jain P, Gulati S, Seth R, Bakhshi S. Vincristine-induced neuropathy in childhood ALL (Acute Lymphoblastic Leukemia) Survivors : Prevelance and Electrophysiological characteristics. J child Neurol. 2013; 1-7
27. Kannarkat G, Lasher E, Schiff D. Neurologic complications of chemotherapy agents. Cur opin Neurol. 2007;20:719-25
28. Poernomo H. Cara pemeriksaan kecepatan hantar saraf. Widjaja D, Basuki M, Poernomo H, penyunting. Dalam : Petunjuk praktis elektrodiagnostik. Bagian ilmu penyakit saraf fakultas kedokteran universitas Airlangga/ RSU dr. Soetomo. Edisi-1. Surabaya: 2003.h.111-60
29. Clinical medical policy department. Nerve conduct velocity (NCV) and Eletromyography (EMG) studies. MCS. 2014: 1-10
30. Medical necessity guidelines. Nerve conduction velocity studies including late response( H-reflex and F wave ). Care allies.2007.1-11
31. Huyn W, Kiernan M. Nerve Conduction studies. AFP. 2011;4:693-697
32. Pease W, Lew H, Johnson E. Johnson’s pratical Elektromyography. Edisi ke-4. Toronto: 2015.H 1-21
33. Smith Lavoie,et al. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Cancer nurs.2013;36(5):E49-60 34. Toopchizadeh V, Barzegar M, Rezamand M, Feiz A. Electrophysiological
consequences of vincristine contained chemotherapy in children : a cohort study. Journal of pediatric neurologi.2009:351-56
